
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy p. 321 - 325 (2008)
Update date:2022-07-29
Topics:
Xiao, Lin-Xiang
Luo, Yi-Ming
Chen, Zhe
Li, Jun
Tang, Rui-Ren
A novel bis-β-diketone organic ligand, 1,1′-(2,6-bispyridyl)bis-3-(p-methoxyphenyl)-1,3-propanedione (L1) and its derivatives, a novel bispyrazole ligand, 2,6-bis(5-(4-methoxyphenyl)-1H-pyrazol-3-yl)pyridine (L2) were designed and synthesized and their complexes with Tb(III) ion were successfully prepared. The ligands and the corresponding metal complexes were characterized by elemental analysis, infrared, proton nuclear magnetic resonance spectroscopy and TG-DTA. Analysis of the IR spectra suggested that the lanthanide metal ion Tb(III) coordinated to the ligands via the nitrogen atom of the pyridine ring and the carbonyl oxygen atoms for ligand L1 and the nitrogen atom of the pyrazole ring for ligand L2. The fluorescence properties of the two complexes in solid state were investigated and it was discovered that the Tb(III) ions could be sensitized by both the ligand (L1) and ligand (L2) to some extent. In particular, the complex of ligand (L2) is a better green luminescent material that could be used as a candidate material in organic light-emitting devices (OLEDs) since it could be much better sensitized by the ligand (L2), and the fluorescence intensity of Tb(III) complex of L2 are almost as twice strong as L1's.
jiangsu senxuan pharmaceutical and chemical co.,ltd
Contact:86-523-87982810
Address:hongqiao industrial zone,taixing,jiangsu china
hangzhou sunchem trading co., ltd.
Contact:13588470430--
Address:Room 406-407, the 4th Building, No549
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
Shanghai Harvest Chemical Ind. Co., Ltd.
Contact:021-51385350
Address:ROOM 806-807, AI LI CHEN BUILDING, No.333 JINGXIANG ROAD, PUDONG DISTRICT, 201206, SHANGHAI
Contact:+86-18653358619
Address:zibo
Doi:10.1021/jo9601674
(1996)Doi:10.1021/jm401075x
(2013)Doi:10.1039/jr9570003798
(1957)Doi:10.1055/s-0033-1339133
(2014)Doi:10.1021/acsmedchemlett.0c00369
(2021)Doi:10.1016/j.tetasy.2003.12.027
(2004)